Low-dose IL-2 therapy limits the reduction in absolute numbers of circulating regulatory T cells in rheumatoid arthritis

BACKGROUND: Circulating regulatory T cells (Tregs) are responsible for mediating immune tolerance and maintaining immunological homeostasis. Decreases in Tregs may be involved in the onset of rheumatoid arthritis (RA). Low-dose interleukin-2 (IL-2) has been considered for the treatment of inflammato...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Ther Adv Musculoskelet Dis
Päätekijät: Zhang, Sheng-Xiao, Wang, Jia, Wang, Cai-Hong, Jia, Rui-Huan, Yan, Ming, Hu, Fang-Yuan, Liu, Guang-Ying, Liu, Xue-Yu, Luo, Jing, Gao, Chong, Li, Xiao-Feng
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: SAGE Publications 2021
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8107675/
https://ncbi.nlm.nih.gov/pubmed/33995604
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1759720X211011370
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia